• Profile
Close

Human pulp responses to partial pulpotomy treatment with TheraCal as compared with Biodentine and ProRoot MTA: A clinical trial

Journal of Endodontics Aug 22, 2017

Bakhtiar H, et al. – The clinical efficacy of TheraCal as compared with Biodentine and ProRoot mineral trioxide aggregate (MTA) for partial pulpotomy were investigated in this study. According to the findings obtained, Biodentine and MTA performed superior to TheraCal when used as partial pulpotomy agent and presented the best clinical results.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay